Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Why the UAE has incurred the wrath of Somalia - 2RFK Jr.’s vaccine advisers plan biggest change yet to childhood schedule
- 3Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution
- 4These 2 companies are teaming up to offer insurance for space debris strikes on satellites
- 5Grammy nominations 2026: Full list of nominees in every major category, including Album of the Year and Best New Artist
- Fundamental Home Items Each Animal person Needs
- MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts
- NASA study shows how satellite 'light pollution' hinders space telescopes
- We may have one thing in common with jellyfish, new research finds
- The Significance of Health Projects in Senior Protection.
- Figure out How to Utilize Your Web based Advertising Degree to Break into the Tech Business
- Every year, she thanks the trooper for the arrest that led to her sobriety
- Turkey, Egypt, Qatar discuss second phase of Gaza ceasefire deal
- RFK Jr. releases new dietary guidelines with emphasis on protein, full-fat dairy
